136 related articles for article (PubMed ID: 24939658)
1. Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis.
Hill QA; Rawstron AC; de Tute RM; Owen RG
Blood; 2014 Aug; 124(8):1296-9. PubMed ID: 24939658
[TBL] [Abstract][Full Text] [Related]
2. Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Paiva B; Chandia M; Vidriales MB; Colado E; Caballero-Velázquez T; Escalante F; Garcia de Coca A; Montes MC; Garcia-Sanz R; Ocio EM; Mateos MV; San Miguel JF
Blood; 2014 Aug; 124(8):1300-3. PubMed ID: 24876564
[TBL] [Abstract][Full Text] [Related]
3. Solitary bone plasmacytomas need to flow.
Dimopoulos MA; Terpos E
Blood; 2014 Aug; 124(8):1209-10. PubMed ID: 25147376
[TBL] [Abstract][Full Text] [Related]
4. Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Fouquet G; Guidez S; Herbaux C; Van de Wyngaert Z; Bonnet S; Beauvais D; Demarquette H; Adib S; Hivert B; Wemeau M; Berthon C; Terriou L; Coiteux V; Macro M; Decaux O; Facon T; Huglo D; Leleu X
Clin Cancer Res; 2014 Jun; 20(12):3254-60. PubMed ID: 24714772
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
7. Solitary plasmacytoma of bone: clinical features, treatment and survival.
Ellis PA; Colls BM
Hematol Oncol; 1992; 10(3-4):207-11. PubMed ID: 1398516
[TBL] [Abstract][Full Text] [Related]
8. Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.
Shen X; Liu S; Wu C; Wang J; Li J; Chen L
Cancer Med; 2021 Jan; 10(2):462-470. PubMed ID: 33145987
[TBL] [Abstract][Full Text] [Related]
9. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli MA; Russo D; Petrucci MT; Bucalossi A; Tura S
Ann Oncol; 1995 Sep; 6(7):687-91. PubMed ID: 8664190
[TBL] [Abstract][Full Text] [Related]
10. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
11. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
12. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
13. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study.
Meis JM; Butler JJ; Osborne BM; Ordóñez NG
Cancer; 1987 Apr; 59(8):1475-85. PubMed ID: 3102035
[TBL] [Abstract][Full Text] [Related]
14. New insights in the treatment of patients with solitary bone plasmacytoma.
Mheidly K; Lamy De La Chapelle T; Hunault M; Benboubker L; Benchalal M; Moreau P; Baugier de Materre A; Decaux O; Laribi K
Leuk Lymphoma; 2019 Nov; 60(11):2810-2813. PubMed ID: 31020888
[No Abstract] [Full Text] [Related]
15. Trends and outcomes of modern staging of solitary plasmacytoma of bone.
Warsame R; Gertz MA; Lacy MQ; Kyle RA; Buadi F; Dingli D; Greipp PR; Hayman SR; Kumar SK; Lust JA; Russell SJ; Witzig TE; Mikhael J; Leung N; Zeldenrust SR; Rajkumar SV; Dispenzieri A
Am J Hematol; 2012 Jul; 87(7):647-51. PubMed ID: 22549792
[TBL] [Abstract][Full Text] [Related]
16. Solitary bone and extramedullary plasmacytoma.
Weber DM
Hematology Am Soc Hematol Educ Program; 2005; ():373-6. PubMed ID: 16304406
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma.
Li QW; Niu SQ; Wang HY; Wen G; Li YY; Xia YF; Zhang YJ
Asian Pac J Cancer Prev; 2015; 16(9):3741-5. PubMed ID: 25987031
[TBL] [Abstract][Full Text] [Related]
18. Solitary plasmacytoma.
Kayrouz T; Jose B; Chu AM; Scott RM
J Surg Oncol; 1983 Sep; 24(1):46-8. PubMed ID: 6887936
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of serum immunoglobulin free light chain and 18F-FDG PET/CT for therapeutic evaluation in a case with multiple plasmacytoma of bone].
Inoue T; Nagai K; Momoi A; Isahai N; Sakai T; Sekiya M
Rinsho Ketsueki; 2015 Apr; 56(4):418-22. PubMed ID: 25971273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
